Christy Mathai’s Market Strategy: Why He Is Buying IT and Insurance Over Defence
As geopolitical tensions cool, the fears of prolonged war-driven inflation are beginning to subside, offering a strategic window for investors. Christy Mathai, Fund Manager at Quantum AMC, is leveraging recent market dips to pivot away from crowded themes and toward undervalued sectors like insurance, logistics, and IT.
Easing Inflation Fears and Earnings Resilience
For much of the recent period, fund managers were braced for a significant hit to corporate earnings due to rising input costs driven by global conflicts. However, Mathai observes that this threat is diminishing. He anticipates that any negative impact on earnings will likely be confined to just one or two quarters rather than extending into the next fiscal year.
Furthermore, Mathai views the RBI's recent FCNR (Foreign Currency Non-Resident) deposit measures as an incremental positive for market stability. With the primary concern shifting from valuation levels to earnings sustainability—and the latter looking increasingly stable—he has used the market correction to build positions in insurance and logistics stocks.
Avoiding the "Crowded Trades": Defence and Chemicals
While many retail and institutional investors are chasing the momentum in the defence and chemical sectors, Mathai is taking a more cautious stance. He notes that the chemical sector is currently battling margin pressures caused by rising freight costs and aggressive supply moves from China. According to Mathai, only a select few companies in this space possess true pricing power, making current valuations unattractive for most.
Similarly, he is sitting on the sidelines regarding the defence sector. Despite the recent correction, he believes these stocks have not yet reached a price point that offers sufficient value after their earlier massive rallies.
The IT Inflection Point and FMCG Tailwinds
Mathai’s strategy for the IT sector is rooted in patience. While current global macro conditions and revenue deflation have led to modest growth guidance of 3-4%, he is looking toward an "AI-driven inflection point." Currently, enterprise AI spending accounts for only an estimated 3-4% of total tech budgets; Mathai expects a massive surge in work for IT services firms once global adoption accelerates. In the interim, he finds value in large-cap IT names offering 5-6% dividend yields and robust cash generation.
In the consumption space, he sees near-term benefits for FMCG due to stabilized GST-related disruptions and rising volume growth. However, he remains wary of paying premium valuations for a sector he expects to see a modest 6-7% normalized long-term growth rate. Instead, he is eyeing consumer discretionary stocks that saw sharp corrections during recent geopolitical volatility.
A Selective Approach to Pharma
In the pharmaceutical sector, Mathai avoids thematic bets in favor of a bottom-up approach. He has been trimming positions where the market has overvalued upcoming drug launches—specifically those tied to GLP-1 optimism. Conversely, he is finding opportunities in companies facing patent expiries, provided they have strategically reinvested past cash surpluses into higher-growth segments.
Key Takeaways
- Strategic Pivots: Mathai is moving away from expensive themes like defence and chemicals to focus on undervalued sectors like insurance, logistics, and IT.
- IT Outlook: He views the current low growth in IT as a precursor to an AI-driven boom, finding value in high dividend yields and cash-rich large-caps.
- Earnings Recovery: The expected impact of war-related inflation on corporate earnings is now projected to be short-term, lasting only one or two quarters.